•  
  •  
 

Abstract

Introduction. National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NFK-KDOQI) recommends thrice weekly hemodialysis (HD) However, in Indonesia, most patients are given HD twice a week. Therefore it is necessary to investigate the clinical features and quality of life in End Stage Renal Disease (ESRD) patients undergoing twice-weekly HD. This study aimed to identify the clinical features and the quality of life in ESRD patients undergoing hemodialysis twice a week. Methods. A cross-sectional study was conducted in ESRD patients undergoing twice-weekly HD and thrice-weekly HD at Cipto Mangunkusumo Hospital and some private hospitals in Jakarta. Blood samples were obtained for laboratory examination. Meanwhile, quality of life were assessed by using Kidney Disease Quality of Life (KDQOL-SF 36). Results. A total of 80 subjects were included in this study, most of them were male and over 50 years old. Some clinical features were significantly higher in twice-weekly HD patients compared to thrice-weekly HD patients. Those features were Interdialytic Weight Gain (IDWG) (mean 4.91% (SD 1.52) and 3.82% (SD 1.28); p= 0.002); albumin (mean 4.05 mg/dl (SD 0.26) and 3.86 mg/dl (SD 0.48); p= 0.027); transferrin saturation (median 25.5% (range 12.0 to 274.0) and 21.95% (5.8 to 84.2); p= 0.004); phosphate level (mean 5.82 mg/dl (SD 1.68) and 5.82 mg/dl (SD 1.68); p= 0.026. Meanwhile, Total Iron Binding Capacity (TIBC) was significantly higher in thrice-weekly HD patients (mean 235.20 μg/dl (SD 55.72) and 273.73 μg/dl (SD 58.29 SB); p= 0.004). Approximately, 68% of twice-weekly HD reached Kt/V >1.8 and 93.3% of thrice-weekly HD reached Kt/V >1.2. Quality of life between the two groups was not significant either on Physical Componet Score (PCS) (p= 0.227), Mental Component Score (MCS) (p= 0.247), and Kidney Disease Component Score (KDCS) (p= 0.889). Conclusions. There are statistically significant differences between clinical features of twice-weekly HD and thrice-weekly HD on examination of IDWG, albumin, transferrin saturation, and phosphate levels which are higher in twice-weekly HD. Whereas, TIBC is higher in thrice-weekly HD group. Meanwhile, the patients quality of life in both groups showed no statistically significant differences.

References

1. Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan RI. Riset kesehatan dasar (riskesdas). Jakarta; Kementerian Kesehatan RI; 2013. hal.88-90. 2. Nakai S, Watanabe Y, Masakane I, Wada A, Shoji T, Hasegawa T, et al. Overview of regular dialysis treatment in japan (as of 31 December 2011). Ther Apher Dial. 2013;17(6):567-611. 3. Mactier R, Hoenich N, Breen C, Davies S, Dudley C, Harden P. Haemodialysis guideline. Dunblane, Scotland: The Renal Association; 2009. p.1-43 4. Kalantar Zadeh K, Unruh M, Zager P, Kovesdy CP, Bargman JM, Chen J, et al. Twice weekly and incremental hemodialysis treatment for initiaton of kidney replacement therapy. Am J Kidney Dis. 2014;64(2):181-6. 5. Bieber B, Qian J, Anand S, Yan Y, Chen N, Wang M, et al. Two tmes weekly hemodialysis in China: frequency associated patient and treatment characteristics and Quality of Life in the China DOPPS. Nephrol Dial Transplant. 2014;29(9):1770-7. 6. Germin-Petrovic D, Devcic I, Lesac A, Mandic M, Soldatic M, Vezmar D. Health related quality of life in the patients on maintenance hemodialysis: the analysis of demographic and clinical factors. Coll Antropol2011;3:687-93.Foley R, Gilbertson DT, Murray T, Collins AJ. Long Interdialytic Interval and Mortality among Patients Receiving Hemodialysis. N Engl J Med.2011;365:1099-107. 7. Afiatin, Supriadi, Sarly, Rusanti. 7th Annual report of indonesian renal registry. Jakarta: PERNEFRI; 2014. p.1-36 8. Bandiara R, Afiatin, Supriadi R, Sarly D, Rusanti I. 6th annual report of indonesian renal registry. Jakarta: PERNEFRI; 2013. p.22 9. Lin YF, Huang JW, Wu MS, Chu TS, Lin SL, Chen YM,, et al. Comparison of residual renal function in patients undergoing twiceweekly versus three times weekly haemodialysis. Nephrology (Carlton). 2009;14(1):59-64. 10. Goh BL, Ong LM, Lim YN. 21th Malaysian dialysis and transplant registry. kuala lumpur: malaysian society of nephrology; 2013. p.1-32 11. Hailen L, Khor L, Lee M, Ng M, Sin AG, Nyunt UW. Trends in chronic kidney failure in Singapore 2010-2011. Singapore: National Registry of Disease Office; 2014. p.1-145. 12. Bross R, Zitterkoph J, Pithia J, Benner D, Rambod M, Kovesdy CP, et al. Association of serum total iron binding capacity and its changes over time with nutritional and clinical outcomes in hemodialysis patients. Am J Nephrol. 2009;29(6):571–81. 13. Arbor Research Collaborative for Health. 2012 Annual report of the dialysis outcomes and practice patterns study: hemodialysis data 1997- 2011 [Internet]. Ann Arbor, Michigan: Arbor Research Collaborative for Health; 2012 [Cited Jan 2016]. Available from: http://www.dopps.org/ annualreport/html/esagroup_c_TAB2011.htm. 14. Ghonemy TA, Farag SE, Soliman SA, Amin EM, Zidan AA. Vascular access complications and risk factors in hemodialysis patients: a single center study. Bull Alexandria Fac. 2016;52(1): 67-71. 15. Lok C, Foley R. AVF Vascullar access morbidity and mortality trends of last decade. Clin J Am Soc Nephrol. 2013;8(7):1213-9. 16. Flythe JE, Curhan GC, Brunelli SM. Shorter length dialysis sessions are associated with increased mortality, independent of body weight. Kidney Int. 2013;83(1):104-13. 17. Brunelli SM, Chertow GM, Ankers ED, Lowrie EG, Thadhani R. Shorter dialysis times are associated with higher mortality among incident hemodialysis patients. Kidney Int. 201;77(7): 630–6. 18. Cheung AK, Nathan WL, Greene T, Agodoa L, Bailey J, Beck G, et al. Effects of high flux hemodialysis on clinical outcomes: Results of the HEMO study. J Am Soc Nephrol. 2003;14(12):3251-63. 19. Oshvandi K, Kavyannejad R, Borzou SR, Gholyaf M. High flux and low flux membranes: Efficacy in hemodialysis. Nurs Midwifery Stud. 2014;3(3)e21764:1-6 20. Upadhyay A, Sosa MA, Jaber BL. Single use versus reusable dialyzers: The known unknowns. Clin J Am Soc Nephrol. 2007;2(5):1079-86. 21. Chertow GM, Johansen KL, Lew N, Lazarus M, Lowrie EG. Vintage, nutritional status and survival in hemodialysis patients. Kidney International.2000;57:1176-81. 22. Rayner HL, Zepel L, Fuller DS, Morgenstern H, Karaboyas A, Culleton BF et al. Recovery time, quality of life and mortality in hemodialysis patients: The DOPPS. Am J Kidney Dis. 2014;64(1):86-94. 23. Flythe JE, Curhan GC, Brunelli SM. Disentangling the ultrafiltration rate mortality association: The respective roles of session length and weight gain. Clin J Am Soc Nephrol. 2013;8(7):1151-61. 24. Stefansson BV, Brunelli SM, Cabrera C, Rosenbaum D, Anum E, Ramakrishnan K, et al. Intradialytic Hypotension and risk of cardiovascular disease. Clin J Am Soc Nephrol. 2014;9:2124-32. 25. Flythe JE, Curhan GC, Brunelli SM. Disentangling the ultrafiltration rate mortality association: The respective roles of session length and weight gain. Clin J Am Soc Nephrol. 2013;8:1151-61. 26. Foley RN, Gilbertson DT, Murray T, Collins AJ. Long interdialytic interval and mortality among patients receiving hemodialysis. N Engl J Med. 2011;365:1099-107. 27. Taskapan H, Ates F, Kaya B. Psychiatric disorders and large interdialytic weight gain in patients on chronic haemodialysis. Nephrology.2005;10(1):15-20. 28. Yamana E. The relationship of clinical laboratory parameters and patient attributes to the quality of life of patients on haemodialysis. Jpn J Nurs Sci. 2009;6(1):9-20. 29. Yusop NB, Mun CY, Shariff ZM, Huat CB. Factors Associated with QoL among Hemodialysis Patients in Malaysia. PLoS One. 2013;8(12):e84152. 30. Bolland M, Grey A, Reid I. Calciu and cardiovascular risks: : 5 years on. Ther Adv Drug Saf. 2013;4(5):199–210. 31. Babitt JL, Lin HY. Mechanisms of Anemia in CKD. J Am Soc Nephrol. 2012;23(10):1631-4. 32. Finkelstein F, Story K, Firanek C, Mendelssohn D, Barre P, Takano T. Health related quality of life and hemoglobin levels in CKD patients. Clin J Am Soc Nephrol. 2009;4(1):33–8. 33. Rezaiee O, Shahgholian N, Shahidi S. Assessment of hemodialysis adequacy and its relationship with individual and personal factors. Iran J Nurs Midwifery Res. 2016;21(6):577-82. 34. Jindal K, Chan CT, Deziel C, Hirsch D, Soroka SD, Tonelli M. Chapter 1: Hemodialysis adequacy in adults. J Am Soc Nephrol. 2006;17(3):S4-7. 35. Bohlke M, Nunes DL, Marini SS, Kitamura C, Andrade M, Von-Gysel MP. Predictor quality of life among patients on dialysis in southern Brazil. Sao Paulo Med J. 2008;126(5):252-6. 36. Apostolou T. Quality of life in the elderly patients on dialysis. Int Urol Nephrol. 2007;39(2):679-83 37. Thaweethamcharoen T, Vasuvattakul S, Noparatayaporn P. Comparison of utility scores and quality of Life Scores in Thai Patients between Twice and Thrice-Weekly Hemodialysis. Siriraj Med J. 2012;64(3):94-7. 38. Rostami Z, Einollahi B, Lessan Pezeshki M, Najaf Abadi AS, Kebar SM, Shahbazian H. Health-related quality of life in hemodialysis patients: an iranian multi-center study. Nephrourol Mon. 2013;5(4):901–2. 39. Anees M, Hameed F, Mumtaz A, Ibrahim M, Saeed KM. Dialysis of related factors affecting quality of life in patients on hemodialysis. Iran J Kidney Dis. 2011;5(1):9-14. 40. Manns BJ, Johnson JA, Taub K, Mortis G, Ghali WA, Donaldson C. Dialysis adequacy and health related quality of life in hemodialysis patietns. ASAIO J. 2002;48(5):565-9. 41. El Sheikh M, Al Ghazaly G. Assessment of hemodialysis adequacy in patients with CKD unit at Tanta University Hospital in Egypt. Indian J Nephrol. 2016;26(6):398–404. 42. Locatelli F, Del Vecchio L. Haemoglobin levels and health related quality of life. Nephrol Dial Transplant. 2014;29(7):1272-74.

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.